Real work doesn’t trend as well as the next big idea in a polished deck - By Dr. Anjo De Heus 360disruption.com

A Friday morning thought.

#Execution isn’t sexy.
#Proven solutions are boring.

Real work doesn’t trend as well as the next big idea in a polished deck.

But execution is what’s actually needed.

Across #Africa, I see enormous #energy around #opportunity — new #alliances, new #councils, new #narratives. AND alongside that, I see people quietly deploying solutions that already work: building #clinics, running #diagnostics, #training teams, fixing #systems, staying when it’s hard.

The gap isn’t #vision.
It’s follow-through.
We don’t lack #innovation.
We lack #disciplined deployment at scale.

#Sustainable #impact rarely comes from what’s new. It comes from what’s tested, adaptable, and repeatable — implemented with patience and accountability.

This isn’t anti-innovation.
It’s pro-outcomes.

Maybe it’s time we made execution a little more #attractive — not because it’s #exciting, but because it’s #effective.

And to those who (you know who you are) quietly execute — often without applause, without panels, without headlines — thank you. YOU ARE the ones who carry the real weight of change!

I’m curious how others see this:

does it resonate that the next chapter isn’t about more ideas, but about bringing proven solutions to scale with discipline and patience? I’d genuinely value perspectives from those who are building, not just talking.

#ExecutionMatters #FromIdeasToImpact #AfricaBuilds
#SustainableDevelopment #RealImpact #HealthSystems
#InfrastructureWithPurpose #AfricaGCC #BeyondTheDeck
DevelopmentInPractice #SystemsChange UNDP World Health Organization #TheWorldBank IFC — International Finance Corporation African Union African Development Bank Group AIM Congress Africa GCC — Council African Business Community In The UAE UAE Africa Networking Group Africa50 Infrastructure Acceleration Fund Africa50 Group Casimir Djoko African Export-Import Bank (Afreximbank) timbuktoo Africa Invest Africa Ltd ANAPI-RDC AUDA-NEPAD Africa Policy Bridge Tank WHX Dubai WHX Labs Dubai Informa African Guarantee Fund African Impact Initiative African Union Development Agency — Health Programmes

Comments

Post a Comment

Popular posts from this blog

Launching a Healthtech Venture in the UAE: A Strategic Guide by 360Disruption

Image
A Strategic Launch Guide by @360disruption The United Arab Emirates (UAE) is quickly becoming one of the most promising launchpads for global healthtech innovation. With forward-thinking leadership, robust infrastructure, and a commitment to becoming a regional healthcare powerhouse, the UAE offers unparalleled opportunities for startups and scale-ups alike. At 360Disruption, we’ve helped companies from the U.S. and Europe navigate this ecosystem — and this guide captures what it takes to enter and scale across the Emirates. The Rise of Healthtech in the UAE: Why It Matters Across the UAE, government-driven healthcare modernization is accelerating. From Abu Dhabi’s academic health initiatives to Dubai’s smart health infrastructure , the country is positioning itself as a global healthtech hub. Key drivers include: Dubai Academic Health Corporation (DAHC) and Dubai Health Authority (DHA) initiatives such as NABIDH (Unified Medical Records) and Sheryan (Smart Licensing). Abu Dhabi...
Read more

Why 360Disruption Is the Partner of Choice for Health-tech Expansion in the Gulf

Image
In today’s competitive global health-tech landscape, entering new markets requires more than a regulatory checklist or a polished investor deck. It requires local traction, commercial validation, and trusted partnerships that can turn plans into performance. That’s where 360Disruption comes in. At 360Disruption, we don’t offer advisory in a vacuum. We execute. Whether you’re a U.S.-based company seeking to expand to the UAE, or a visionary startup looking for a trusted partner to bring your solution to life, we offer a pathway grounded in reality and built for scale Three Paths to Market Entry. One Strategic Engine. Every company we work with is different. Some are still testing product-market fit. Others are ready to scale. A few simply need the right on-the-ground team to carry the commercial flag. That’s why we built our platform around three adaptable tracks: 1. Incubation We work with early-stage companies or first-time entrants into the region to de-risk market entry, validate lo...
Read more

Why the UAE’s Medical Device Classification System is a Game-Changer for U.S. Healthtech Companies

Image
Why the UAE’s Medical Device Classification System is a Game-Changer for U.S. Healthtech Companies   The United Arab Emirates (UAE) has quietly built one of the world’s most innovation-friendly pathways for medical device companies—and now, more than ever, U.S.-based healthtech startups and scaleups should take notice. Unlike the FDA’s formal and risk-heavy classification system, the UAE’s Ministry of Health and Prevention (MOHAP) offers a flexible, product-specific, and internationally harmonized framework that accelerates market access, reduces cost, and creates entry into a health-conscious, tech-forward region. This is not just an alternative to the U.S. regulatory maze—it’s a springboard into the broader Middle East, Africa, and Asia.   UAE vs. FDA: Key Differences at a Glance Criteria FDA (USA) MOHAP / UAE Classification Class I, II, III Class I, IIa, IIb, III (EU MDR aligned) Approach Risk-based Risk-based + product-specific Timeline 12–36 months Weeks to classification...
Read more